These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 30594914)
1. DSCAM-AS1 up-regulation in invasive ductal carcinoma of breast and assessment of its potential as a diagnostic biomarker. Khorshidi H; Azari I; Oskooei VK; Taheri M; Ghafouri-Fard S Breast Dis; 2019; 38(1):25-30. PubMed ID: 30594914 [TBL] [Abstract][Full Text] [Related]
2. Assessment of expression of interferon γ (IFN-G) gene and its antisense (IFNG-AS1) in breast cancer. Yaghoobi H; Azizi H; Oskooei VK; Taheri M; Ghafouri-Fard S World J Surg Oncol; 2018 Oct; 16(1):211. PubMed ID: 30336781 [TBL] [Abstract][Full Text] [Related]
3. LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer. Ma Y; Bu D; Long J; Chai W; Dong J J Cell Physiol; 2019 Mar; 234(3):2880-2894. PubMed ID: 30203615 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA (lncRNA) DSCAM-AS1 is upregulated in breast cancer. Tarighi M; Khalaj-Kondori M; Hosseinzadeh A; Abtin M Breast Dis; 2021; 40(2):63-68. PubMed ID: 33554879 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma. Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018 [TBL] [Abstract][Full Text] [Related]
6. The clinical significance of circulating DSCAM-AS1 in patients with ER-positive breast cancer and construction of its competitive endogenous RNA network. Moradi MT; Fallahi H; Rahimi Z Mol Biol Rep; 2020 Oct; 47(10):7685-7697. PubMed ID: 33040318 [TBL] [Abstract][Full Text] [Related]
7. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2. Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164 [TBL] [Abstract][Full Text] [Related]
8. Expression analysis of vimentin and the related lncRNA network in breast cancer. Mohebi M; Ghafouri-Fard S; Modarressi MH; Dashti S; Zekri A; Kholghi-Oskooei V; Taheri M Exp Mol Pathol; 2020 Aug; 115():104439. PubMed ID: 32283061 [TBL] [Abstract][Full Text] [Related]
9. Expression analysis of AFAP1-AS1 and AFAP1 in breast cancer. Dianatpour A; Faramarzi S; Geranpayeh L; Mirfakhraie R; Motevaseli E; Ghafouri-Fard S Cancer Biomark; 2018; 22(1):49-54. PubMed ID: 29439313 [TBL] [Abstract][Full Text] [Related]
10. The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression. Niknafs YS; Han S; Ma T; Speers C; Zhang C; Wilder-Romans K; Iyer MK; Pitchiaya S; Malik R; Hosono Y; Prensner JR; Poliakov A; Singhal U; Xiao L; Kregel S; Siebenaler RF; Zhao SG; Uhl M; Gawronski A; Hayes DF; Pierce LJ; Cao X; Collins C; Backofen R; Sahinalp CS; Rae JM; Chinnaiyan AM; Feng FY Nat Commun; 2016 Sep; 7():12791. PubMed ID: 27666543 [TBL] [Abstract][Full Text] [Related]
11. Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer. Dashti S; Ghafouri-Fard S; Esfandi F; Oskooei VK; Arsang-Jang S; Taheri M Exp Mol Pathol; 2020 Feb; 112():104359. PubMed ID: 31837323 [TBL] [Abstract][Full Text] [Related]
12. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer. Tantai J; Hu D; Yang Y; Geng J Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353 [TBL] [Abstract][Full Text] [Related]
13. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients. Deng J; Liang Y; Liu C; He S; Wang S Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625 [TBL] [Abstract][Full Text] [Related]
14. DSCAM-AS1 regulates the G Sun W; Li AQ; Zhou P; Jiang YZ; Jin X; Liu YR; Guo YJ; Yang WT; Shao ZM; Xu XE Cancer Med; 2018 Dec; 7(12):6137-6146. PubMed ID: 30430768 [TBL] [Abstract][Full Text] [Related]
15. Expression Analysis of OIP5-AS1 in Non-Small Cell Lung Cancer. Esfandi F; Kholghi Oskooei V; Taheri F; Kiani A; Taheri M; Ghafouri-Fard S Klin Onkol; 2018; 31(4):260-263. PubMed ID: 30541307 [TBL] [Abstract][Full Text] [Related]
16. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer. Li W; Li N; Kang X; Shi K Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690 [TBL] [Abstract][Full Text] [Related]
17. Expression analysis of long non-coding ATB and its putative target in breast cancer. Nikpayam E; Soudyab M; Tasharrofi B; Sarrafzadeh S; Iranpour M; Geranpayeh L; Mirfakhraie R; Gharesouran J; Ghafouri-Fard S Breast Dis; 2017; 37(1):11-20. PubMed ID: 28598827 [TBL] [Abstract][Full Text] [Related]
18. Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues. Esfandi F; Taheri M; Omrani MD; Shadmehr MB; Arsang-Jang S; Shams R; Ghafouri-Fard S BMC Cancer; 2019 Mar; 19(1):222. PubMed ID: 30866866 [TBL] [Abstract][Full Text] [Related]
19. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer. Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877 [TBL] [Abstract][Full Text] [Related]
20. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]